STOCK TITAN

United Health Products delays Q3 financial report

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
NT 10-Q

Rhea-AI Filing Summary

United Health Products, Inc. (UEEC) said it could not file its Form 10-Q for the quarter ended September 30, 2026, by the prescribed deadline without unreasonable effort or expense. The company attributed the delay to a widespread Microsoft cloud services disruption beginning November 12, 2026, which impaired access to SharePoint and email servers used in its quarter-close and disclosure review and interrupted exchanges of draft financial statements and supporting documents with its independent registered public accounting firm. UEEC currently anticipates filing within the five-calendar-day extension period under Rule 12b-25.

Extension period 5 calendar days UEEC currently anticipates filing its Form 10-Q within the Rule 12b-25 extension period.
Rule 12b-25 regulatory
"five-calendar-day extension period provided by Rule 12b-25"
Rule 12b-25 is an SEC filing provision that lets a company notify regulators and the public that it cannot file a required periodic report (like a quarterly or annual report) on time and explains the reason for the delay. For investors, the notice is a formal heads-up that financial information will arrive late—similar to a company calling to say it will be late turning in homework—so it signals increased uncertainty and may affect trading and risk assessments until the filing is available.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When does UEEC expect to file its September 2026 10-Q?

UEEC currently anticipates filing within the five-calendar-day extension period provided by Rule 12b-25.

Why was UEEC's September 2026 10-Q delayed?

UEEC attributed the delay to a widespread Microsoft cloud services disruption beginning November 12, 2026. The disruption affected its access to document management, collaboration and email services used in the quarter-close and disclosure review process, and interrupted exchanges with its independent registered public accounting firm.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

 

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549 

 

FORM 12b-25

 

NOTIFICATION OF LATE FILING

 

 

(Check one):

☐ Form 10-K      ☐ Form 20-F      ☐ Form 11-K       ☒ Form 10-Q      ☐  Form 10-D      ☐ Form N-SAR      ☐ Form N-CSR

 

 

 

 

For Period Ended: September 30, 2026                                              

 

 

 

 

☐

Transition Report on Form 10-K

 

 

 

 

☐ 

Transition Report on Form 20-F

 

 

 

 

☐ 

Transition Report on Form 11-K

 

 

 

 

☐

Transition Report on Form 10-Q

 

 

 

 

☐

Transition Report on Form N-SAR

 

 

 

 

For the Transition Period Ended: ________________________

 

Read Instruction (on back page) Before Preparing Form. Please Print or Type.

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

 

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

 

PART I — REGISTRANT INFORMATION

 

United Health Products, Inc.

 

Full Name of Registrant

 

 

 

 

 

Former Name if Applicable

 

 

 

320 Boston Post Road, Suite 180

 

Address of Principal Executive Office (Street and Number)

 

 

 

Darien, CT 06820

 

City, State and Zip Code

 

 

 

 

PART II — RULES 12b-25(b) AND (c)

 

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

 

☒

(a)

The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;

 

 

(b)

The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and

 

 

(c)

The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

 

PART III — NARRATIVE

 

State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report portion thereof, could not be filed within the prescribed time period.

 

(Attach extra Sheets if Needed)

 

The Registrant was unable to file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2026 within the prescribed time period without unreasonable effort or expense due to a widespread service disruption affecting Microsoft cloud services beginning on November 12, 2026. The disruption impaired the Registrant’s access to its document management and collaboration platforms on MS SharePoint and to emails servers used in the Registrant’s quarterly books close and disclosure review process, and interrupted the exchange of draft financial statements and supporting documentation with the Registrant's independent registered public accounting firm, which impacted the Registrant’s ability to complete and review its interim financial statements prior to the due date as a result. The Registrant is geographically remote from its independent registered public accounting firm’s location and the Registrant did not have an alternative to complete its Quarterly Report on Form 10-Q and get the information to them securely without unreasonable effort or expense; particularly not knowing how long the disruption would persist. The Registrant currently anticipates filing the Quarterly Report within the five-calendar-day extension period provided by Rule 12b-25.

 

PART IV — OTHER INFORMATION

 

(1)

Name and telephone number of person to contact in regard to this notification

 

Brian Thom

 

(475)

 

755-1005

(Name)

 

(Area Code)

 

(Telephone Number)

 

(2)

Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Registrant Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). 

 

Yes ☒     No ☐

 

 

(3)

Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? 

 

 Yes ☐      No ☒

 

 

2

 

 

United Health Products, Inc.

(Name of Registrant as Specified in Charter)

 

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: November 17, 2026

By:

/s/ Brian Thom

 

 

 

 

Brian Thom

Chief Executive Officer

 

 

 

3

 

 

Keep reading